Logo CICANCER

CIC Events

Inherited and acquired genetic biomarkers in patients with Mast Cell Activation Syndromes and Mastocytosis 10/04/2025

Inherited and acquired genetic biomarkers in patients with Mast Cell Activation Syndromes and Mastocytosis

Paula Navarro — Centro de Investigación del Cáncer. Universidad de Salamanca - CSIC

Tuning the ribosome in health and disease 24/04/2025

Tuning the ribosome in health and disease

Anders H. Lund — Biotech Research and Innovation Centre University of Copenhagen

Preclinical and clinical evaluation of belantamab mafodotin based immunotherapy combinations in multiple myeloma 08/05/2025

Preclinical and clinical evaluation of belantamab mafodotin based immunotherapy combinations in multiple myeloma

Mauro Lorenzo Mohamed — Centro de Investigación del Cáncer. Universidad de Salamanca - CSIC

Rational engineering of a bacteria for human lung therapy 15/05/2025

Rational engineering of a bacteria for human lung therapy

Luis Serrano — CRG. Barcelona

Academic model for CAR-T development: ARI0002h for multiple myeloma and beyond 22/05/2025

Academic model for CAR-T development: ARI0002h for multiple myeloma and beyond

Carlos Fernández de Larrea — Hospital Clínic de Barcelona



Past Events

Defensa de tesis doctoral: Novel immunophenotypic approaches to improve the diagnostic study of mature T- and NK-cell neoplasms 04/04/2025

Defensa de tesis doctoral: Novel immunophenotypic approaches to improve the diagnostic study of mature T- and NK-cell neoplasms

Francisco Javier Morán Plata — PD. Biología y Clínica del Cáncer.

Dissecting the function of copy number alterations in cancer 03/04/2025

Dissecting the function of copy number alterations in cancer

Francisco M. Barriga — VHIO, Barcelona

Cellular senescence as a therapeutic target 27/03/2025

Cellular senescence as a therapeutic target

Jesús Gil — Imperial College London, UK

Markers and vulnerabilities of senescent cells in post-therapy tumors 20/03/2025

Markers and vulnerabilities of senescent cells in post-therapy tumors

José Alberto López — Centro de Investigación del Cáncer. Universidad de Salamanca - CSIC